Clinical trial
A Randomized Controlled Clinical Trial on the Antipyretic Efficacy of Oral Paracetamol, Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever to Emergency Department
NCT01891435 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Clinical Trial on the Antipyretic Efficacy of Oral Paracetamol, Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever to Emergency Department
- Lead sponsor
- Hamad Medical Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- April 30, 2013
- Enrollment
- 434 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fever, reduction in temperature